These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2835159

  • 1. [Mechanism of action of ibopamine: pharmacological effects of epinine and other metabolites].
    Ferrini R, Merlo L, Miragoli G.
    Cardiologia; 1988 Jan; 33(1):49-53. PubMed ID: 2835159
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine.
    Nichols AJ, Ruffolo RR.
    J Pharmacol Exp Ther; 1987 Aug; 242(2):455-63. PubMed ID: 3039117
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ, Smith JM, Shebuski RJ, Ruffolo RR.
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [Abstract] [Full Text] [Related]

  • 4. Coronary vascular activity of the novel inotropic pro-drug ibopamine and the de-esterified active form epinine.
    Ohlstein EH, Kopia GA, Ruffolo RR.
    Arzneimittelforschung; 1988 Dec; 38(12):1790-2. PubMed ID: 3245851
    [Abstract] [Full Text] [Related]

  • 5. Effect of dopamine, ibopamine, and epinine on alpha- and beta-adrenoceptors in canine pulmonary circulation.
    Shebuski RJ, Smith JM, Ruffolo R.
    Fundam Clin Pharmacol; 1989 Dec; 3(3):211-21. PubMed ID: 2548941
    [Abstract] [Full Text] [Related]

  • 6. Ibopamine.
    Arzneimittelforschung; 1986 Feb; 36(2A):285-407. PubMed ID: 3707639
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of plasma cholinesterase prevents the dopamine DA-1 receptor mediated renal vasodilation produced by ibopamine.
    Nichols AJ, Shebuski RJ, Ruffolo RR.
    Eur J Pharmacol; 1987 Sep 23; 141(3):515-8. PubMed ID: 3666046
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the alpha adrenoceptor activity of dopamine, ibopamine and epinine in the pulmonary circulation of the dog.
    Shebuski RJ, Fujita T, Smith JM, Ruffolo RR.
    J Pharmacol Exp Ther; 1987 Apr 23; 241(1):6-12. PubMed ID: 3033210
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular and renal action of dopaminergic prodrugs.
    Casagrande C, Merlo L, Ferrini R, Miragoli G, Semeraro C.
    J Cardiovasc Pharmacol; 1989 Apr 23; 14 Suppl 8():S40-59. PubMed ID: 2483441
    [Abstract] [Full Text] [Related]

  • 10. Effect of ibopamine on diuresis and arterial blood pressure in anesthetized rats and its interactions with dopaminergic and alpha- and beta-adrenergic antagonists.
    Ferrini R, Miragoli G.
    Arzneimittelforschung; 1986 Feb 23; 36(2A):323-6. PubMed ID: 2871844
    [Abstract] [Full Text] [Related]

  • 11. Activity of ibopamine on some isolated organs.
    Ferrini R, Miragoli G.
    Arzneimittelforschung; 1986 Feb 23; 36(2A):312-7. PubMed ID: 3458467
    [Abstract] [Full Text] [Related]

  • 12. Clinical pharmacology of ibopamine.
    Itoh H.
    Am J Med; 1991 May 29; 90(5B):36S-42S. PubMed ID: 1675550
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological profile of ibopamine. A summary of experiments on anaesthesized dogs.
    Marchetti GV.
    Cardiology; 1990 May 29; 77 Suppl 5():22-9. PubMed ID: 1980631
    [Abstract] [Full Text] [Related]

  • 14. Pharmacotherapeutic profile of ibopamine in heart failure.
    Taylor SH.
    J Cardiovasc Pharmacol; 1989 May 29; 14 Suppl 8():S118-23. PubMed ID: 2483437
    [Abstract] [Full Text] [Related]

  • 15. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in rats.
    Pocchiari F, Pataccini R, Castelnovo P, Longo A, Casagrande C.
    Arzneimittelforschung; 1986 Feb 29; 36(2A):334-40. PubMed ID: 3707645
    [Abstract] [Full Text] [Related]

  • 16. Activity of ibopamine on central nervous system in mice and rats.
    Ferrini R, Miragoli G, Sala R, Reggiani A.
    Arzneimittelforschung; 1986 Feb 29; 36(2A):327-30. PubMed ID: 3707643
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
    Kopia GA, Ohlstein EH, Ruffolo RR.
    J Pharmacol Exp Ther; 1988 Aug 29; 246(2):434-40. PubMed ID: 3404441
    [Abstract] [Full Text] [Related]

  • 19. Effects of ibopamine on acute cardiac failure following experimental coronary occlusion in dogs.
    Marchetti G, Merlo L.
    Arzneimittelforschung; 1986 Feb 29; 36(2A):331-3. PubMed ID: 3707644
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
    De Vita C, Triulzi E, Devizzi S, Colombo G, Palvarini M, Pocchiari F, Pataccini R.
    Arzneimittelforschung; 1986 Feb 29; 36(2A):349-54. PubMed ID: 3707648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.